Samer Alsaid։ Older Patients With Atrial Fibrillation Benefit From FXI Inhibition
Samer Alsaid, Cardiologist and Vascular Medicine Specialist, shared a post on LinkedIn about a recent article he co-authored with his colleagues, adding:
՛՛Bleeding risk rises steadily with age in patients with atrial fibrillation — underscoring the need for safer anticoagulant options in older individuals.
In our prespecified analysis of the phase 2b AZALEA-TIMI 71 trial, now published in JAMA Cardiology, the FXI inhibitor abelacimab consistently reduced bleeding compared with rivaroxaban across age groups, with the potential for greater absolute reductions in older patients.
FXI inhibition may become a particularly attractive option for older patients with AF, but phase 3 trial results are needed to define its efficacy and overall benefit-risk balance.
Grateful to an outstanding group of collaborators, mentors, and the AZALEA-TIMI 71 investigators who made this work possible․՛՛
Title: Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation
Authors: Samer Al Said, Siddharth M. Patel, Robert P. Giugliano, David A. Morrow, Erica L. Goodrich, Sabina A. Murphy, Bruce Hug, Sanobar Parkar, Shih-Ann Chen, Shaun G. Goodman, Boyoung Joung, Robert G. Kiss, Wojciech Wojakowski, Jeffrey I. Weitz, Dan Bloomfield, Marc S. Sabatine, Christian T. Ruff
Read the Full Article on JAMA Cardiology․
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 5, 2026, 10:45Mohammed Ayaz Ali։ HIT – When an Anticoagulant Causes Thrombosis
-
Oct 5, 2026, 10:24Vishnu Priya Pulipati: The Endocrinologist’s Role in Lp(a) and Cardiovascular Risk Reduction
-
Oct 5, 2026, 09:59William McKeown – A Busy Week with the European Haemophilia Consortium
-
Oct 5, 2026, 09:46Megan Buchholz – Celebrating Apheresis Awareness Day 2026 at St. Michael’s Hospital
-
Oct 5, 2026, 09:34ITP Myth vs. Fact – A Common Misconception – ITP Support Association
-
Oct 5, 2026, 09:20Jan Sloves: Medial Thigh Venous Perforators – Why Diameter Isn’t the Whole Story
-
Oct 5, 2026, 09:16Emmanuele Kouvousis: ASH Sets New Standards for Diagnosing Iron Deficiency
-
Oct 5, 2026, 09:12Arun V J: Fresh Whole Blood vs Evidence-Based Transfusion
-
Oct 5, 2026, 09:06Edward Lee Carter: NOTION-4 – HALT and Clinical Outcomes